scholarly article | Q13442814 |
P50 | author | Nancy S. Green | Q37840450 |
Suzanne Bakken | Q61465965 | ||
P2093 | author name string | Susan L Rosenthal | |
Haomiao Jia | |||
Arlene Smaldone | |||
Deepa Manwani | |||
Sally Findley | |||
Sergio Matos | |||
L Adriana Matiz | |||
P2860 | cites work | Transition and sickle cell disease | Q26863538 |
Induction of fetal hemoglobin in sickle cell disease. | Q33539271 | ||
Dyadic measures of the parent-child relationship during the transition to adolescence and glycemic control in children with type 1 diabetes | Q33744978 | ||
Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV. | Q33753905 | ||
How we design feasibility studies | Q33809081 | ||
How I use hydroxyurea to treat young patients with sickle cell anemia | Q33985120 | ||
Blood glucose monitoring and glycemic control in adolescence: contribution of diabetes-specific responsibility and family conflict | Q34008123 | ||
Medication adherence among pediatric patients with sickle cell disease: a systematic review. | Q34567690 | ||
Construct validity of the Work Productivity and Activity Impairment questionnaire across informal caregivers of chronically ill older patients | Q34580233 | ||
Hydroxyurea for the treatment of sickle cell anemia | Q34764729 | ||
Health-related quality of life in children and adolescents with sickle cell disease | Q35072375 | ||
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). | Q35097294 | ||
Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyurea | Q35230853 | ||
Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? | Q35234959 | ||
PedsQL™ sickle cell disease module: feasibility, reliability, and validity | Q35545910 | ||
Measuring resource utilization in patient-oriented comparative effectiveness research: a psychometric study of the Resource Utilization Questionnaire | Q35612335 | ||
Role of habit in adherence to medical treatment | Q36078667 | ||
From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia | Q36154109 | ||
Parent and adolescent distribution of responsibility for diabetes self-care: links to health outcomes | Q36234033 | ||
Trust in physicians and racial disparities in HIV care | Q36321589 | ||
Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease | Q36763705 | ||
Predictive validity of a medication adherence measure in an outpatient setting | Q36925564 | ||
Community Health Workers as Support for Sickle Cell Care | Q37032152 | ||
Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea | Q37059877 | ||
Psychological aspects and hospitalization for pain crises in youth with sickle-cell disease | Q37097814 | ||
Validity of the Pediatric Quality Of Life Inventory for youth with sickle cell disease | Q37133670 | ||
National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease | Q37155243 | ||
The performance of the PedsQL generic core scales in children with sickle cell disease | Q37155370 | ||
The role of lay health workers in pediatric chronic disease: a systematic review | Q37242509 | ||
Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease | Q37244000 | ||
The validity and reproducibility of a work productivity and activity impairment instrument | Q74822877 | ||
A framework for the study of self- and family management of chronic conditions | Q79207968 | ||
Identifying barriers to medication adherence in adolescent transplant recipients | Q80375574 | ||
The number of people with sickle-cell disease in the United States: national and state estimates | Q82320507 | ||
Community health worker insights on their training and certification | Q83147414 | ||
Shorter hospitalization trends among children with sickle cell disease | Q83186797 | ||
Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations | Q83572756 | ||
Population estimates of sickle cell disease in the U.S. | Q83889628 | ||
Community health workers as drivers of a successful community-based disease management initiative | Q83931263 | ||
Text4Health: a qualitative evaluation of parental readiness for text message immunization reminders | Q84734642 | ||
Building a consensus on community health workers' scope of practice: lessons from New York | Q84809885 | ||
Allocation of family responsibility for illness management in pediatric HIV. | Q37292613 | ||
Perceived barriers to clinic appointments for adolescents with sickle cell disease | Q37361190 | ||
Adherence to hydroxyurea therapy in children with sickle cell anemia | Q37512157 | ||
Brief report: development of the inflammatory bowel disease family responsibility questionnaire | Q37535314 | ||
Evaluating adherence to medication in children and adolescents with HIV. | Q37590520 | ||
Influences on adherence to pediatric asthma treatment: a review of correlates and predictors | Q37649421 | ||
Medication adherence in the asthmatic child and adolescent | Q37942016 | ||
Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial | Q38005665 | ||
Acute care utilization and rehospitalizations for sickle cell disease | Q38374639 | ||
Hydroxyurea Use in Young Children With Sickle Cell Anemia in New York State | Q39672020 | ||
Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. | Q39677885 | ||
The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children | Q39700582 | ||
Facilitators and barriers to self-management of type 2 diabetes among urban African American adults: focus group findings | Q39956165 | ||
Exploring pregnant women's views on influenza vaccination and educational text messages | Q39957532 | ||
Community-based care coordination: practical applications for childhood asthma | Q40006384 | ||
Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment | Q40738128 | ||
Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis | Q41087808 | ||
Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease | Q41983509 | ||
Barriers to adherence of deferoxamine usage in sickle cell disease | Q42642783 | ||
Treatment adherence in patients with sickle cell anemia | Q43200152 | ||
The allocation of family responsibility for asthma management tasks in African-American adolescents | Q43437947 | ||
Five years of experience with hydroxyurea in children and young adults with sickle cell disease | Q43615402 | ||
Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes | Q44082230 | ||
PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations | Q44207239 | ||
Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease | Q44664007 | ||
At what age do children start taking daily asthma medicines on their own? | Q45828982 | ||
Hydroxyurea use in patients with sickle cell disease in a Medicaid population | Q46046652 | ||
Mammography adherence and beliefs in a sample of low-income African American women | Q46628518 | ||
Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease. | Q48004843 | ||
Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. | Q50972375 | ||
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease. | Q51065755 | ||
Supporting the health care transition from adolescence to adulthood in the medical home. | Q51553770 | ||
Lessons learned from a community-academic initiative: the development of a core competency-based training for community-academic initiative community health workers. | Q51781488 | ||
An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. | Q52897435 | ||
Mortality in sickle cell disease. Life expectancy and risk factors for early death. | Q55065788 | ||
High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease | Q58883327 | ||
Assessing family sharing of diabetes responsibilities | Q68632299 | ||
Deviation from developmentally appropriate self-care autonomy. Association with diabetes outcomes | Q71286967 | ||
Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial | Q71571027 | ||
Medication adherence in pediatric asthma: reasoning, responsibility, and behavior | Q73529900 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | hydroxycarbamide | Q212272 |
randomized controlled trial | Q1436668 | ||
sickle-cell disease | Q185034 | ||
study protocol | Q111908491 | ||
P304 | page(s) | 134-142 | |
P577 | publication date | 2016-06-17 | |
P1433 | published in | Contemporary Clinical Trials | Q5164971 |
P1476 | title | Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease | |
P478 | volume | 49 |
Q92809941 | Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease |
Q90727421 | HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol |
Q52639727 | HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease. |
Q89988564 | Quality of Life of Latino and Non-Latino Youth With Sickle Cell Disease as Reported by Parents and Youth |
Q48232192 | Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study |
Q28066704 | Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis |
Search more.